Wang Y, Delcher C, Li Y, Goldberger BA, Reisfield GM. Overlapping prescriptions of opioids, benzodiazepines, and carisoprodol: “Holy Trinity” prescribing in the state of Florida. Drug Alcohol Depend. In press.

Delcher C, Slavova S, Wang Y, Henry SG. Opioid Prescribing Before and After the Centers for Disease Control and Prevention’s 2016 Opioid Guideline. Ann Intern Med. 2019;170(8):581-582. doi:10.7326/L19-0053.

Finkelstein MJ, Chronister CW, Stanley C, Ogilvie LM, Goldberger BA. Analysis of Acetyl Fentanyl in Postmortem Specimens by Gas Chromatography-Mass Spectrometry (GC-MS): Method Validation and Case Report. J Anal Toxicol. 2019;43(5):392-398. doi:10.1093/jat/bky108.

Goodin AJ, Brown JD, Delcher C, Freeman PR, Talbert J, Henry SG, Roussos-Ross D. Perception of prescription drug monitoring programs as a prevention tool in primary medical care. Res Social Adm Pharm. March 2019. doi:10.1016/j.sapharm.2019.03.012.

Jannetto PJ, Helander A, Garg U, Janis GC, Goldberger B, Ketha H. The Fentanyl Epidemic and Evolution of Fentanyl Analogs in the United States and the European Union. Clin Chem. 2019;65(2):242-253. doi:10.1373/clinchem.2017.281626.

Li Y, Delcher C, Brown JD, Wei Y-J, Reisfield GM, Winterstein AG. Impact of Schedule IV controlled substance classification on carisoprodol utilization in the United States: An interrupted time series analysis. Drug Alcohol Depend. 2019;202:172-177. doi:10.1016/j.drugalcdep.2019.05.025.

Morrow JB, Ropero-Miller JD, Catlin ML, Winokur AD, Cadwallader AB, Staymates JL, Williams SR, McGrath JG, Logan BK, McCormick MM, Nolte KB, Gilson TP, Menendez MJ, Goldberger BA. The Opioid Epidemic: Moving Toward an Integrated, Holistic Analytical Response. J Anal Toxicol. 2019;43(1):1-9. doi:10.1093/jat/bky049.

Muñoz MA, Delcher C, Dal Pan GJ, Kortepeter CM, Wu E, Wei Y-JJ, Xiao H, Winterstein AG. Impact of a New Consumer Form on the Quantity and Quality of Adverse Event Reports Submitted to the United States Food and Drug Administration. Pharmacotherapy. September 2019. doi:10.1002/phar.2325.

Quast T, Bright MA, Delcher C. The relationship between foster care entries and high-dose opioid prescribing in California. Addict Behav. 2019;93:52-58. doi:10.1016/j.addbeh.2019.01.015.

Slavova S, Delcher C, Buchanich JM, Bunn TL, Goldberger BA, Costich JF. Methodological Complexities in Quantifying Rates of Fatal Opioid-Related Overdose. Curr Epidemiol Rep. 2019;6(2):263-274. doi:10.1007/s40471-019-00201-9.

Conner KL, Meadows AL, Delcher C, Talbert JC. Neonatal Abstinence Syndrome and Childhood Mental Health Conditions, 2009-2015: Commercial Versus Medicaid Populations. Psychiatr Serv. October 2019:appips201900180. doi:10.1176/

Pauly NJ, Slavova S, Delcher C, Freeman PR, Talbert J. Features of prescription drug monitoring programs associated with reduced rates of prescription opioid-related poisonings. Drug Alcohol Depend. 2018;184:26-32. doi:10.1016/j.drugalcdep.2017.12.002.

Delcher C, Wang Y, Goodin A, Freeman PR, Reisfield GM. Rapid Expansion of the Opioid Ecosystem: National Implications for Prescriber–Pharmacist Communication. American Journal of Preventive Medicine. 2018;55(5):656-661. doi:10.1016/j.amepre.2018.05.003.

O’Donnell JK, Halpin J, Mattson CL, Goldberger BA, Gladden RM. Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 – 10 States, July-December 2016. MMWR Morb Mortal Wkly Rep. 2017;66(43):1197-1202. doi:10.15585/mmwr.mm6643e1.

Triplett K, Goodin A, Delcher C, Brown J, Roussos-Ross K. Opioid Drug Exposures and Health Care Utilization Measures Associated with Neonatal Abstinence Syndrome in Florida , 2011-2015. In: ; 2017.

Perez NM, Jennings WG, Wang Y, Delcher C. Law Enforcement Officers’ Perceptions of Florida’s Prescription Drug Monitoring Program. Journal of Contemporary Criminal Justice. 2017;33(4):368-379. doi:10.1177/1043986217724291.

Delcher C, Wang Y, Young HW, Goldberger BA, Schmidt S, Reisfield GM. Trends in Florida’s Prescription Drug Monitoring Program registration and utilization: Implications for increasing voluntary use. J Opioid Manag. 2017;13(5):283-289. doi:10.5055/jom.2017.0397.

Delcher C, Chen G, Wang Y, Slavova S, Goldberger BA. Fatal poisonings involving propoxyphene before and after voluntary withdrawal from the United States’ market: An analysis from the state of Florida. Forensic Sci Int. 2017;280:228-232. doi:10.1016/j.forsciint.2017.10.008.

Peterson AB, Gladden RM, Delcher C, Spies E, Garcia-Williams A, Wang Y, Halpin J, Zibbell J, McCarty CL, DeFiore-Hyrmer J, DiOrio M, Goldberger BA. Increases in Fentanyl-Related Overdose Deaths — Florida and Ohio, 2013–2015. MMWR Morbidity and Mortality Weekly Report. 2016;65(33):844-849. doi:10.15585/mmwr.mm6533a3.

Lee D, Chronister CW, Broussard WA, Utley-Bobak SR, Schultz DL, Vega RS, Goldberger BA. Illicit Fentanyl-Related Fatalities in Florida: Toxicological Findings. J Anal Toxicol. 2016;40(8):588-594. doi:10.1093/jat/bkw087.

Delcher C, Wang Y, Wagenaar AC, Goldberger BA, Cook RL, Maldonado-Molina MM. Prescription and Illicit Opioid Deaths and the Prescription Drug Monitoring Program in Florida. Am J Public Health. 2016;106(6):e10-e11. doi:10.2105/AJPH.2016.303104.

Wang Y, Cottler LB, Striley CW. Differentiating patterns of prescription stimulant medical and nonmedical use among youth 10-18 years of age. Drug Alcohol Depend. 2015;157:83-89. doi:10.1016/j.drugalcdep.2015.10.006.